Catapulse in the treatment of cataracts
“It’s almost like a magnet. The nucleus segments basically stick to the tip of the Catapulse system while they’re being removed, because there’s no ultrasound. It’s exclusively vacuum-driven,” said Dr Antonio Mendez MD, of Mexico, during his presentation during the XXXI ESCRS Congress in Amsterdam, The Netherlands.
Referring to the lens removal as “phacoaspiration,” Dr Mendez explained that the controlled pulsed vacuum of the Catapulse removes each of the nucleus sections without utilising ultrasound energy.
“There is no assembly, no heat and no moving parts inside the eye,” he continued. “This led to a low 7.3 per cent endothelial cell density loss at one month after surgery.”
The Catapulse system uses two 1.2mm stab incisions and functions similarly to standard irrigation and aspiration, with a small, ergonomic and, according to Dr Mendez, very comfortable handpiece.
Tags: intraocular pressure, optical coherence tomography
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.